Results of neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fuluorouracil for advanced esophageal cancer.

被引：1
|
作者：
Emi, Manabu
Hamai, Yoichi
Ibuki, Yuta
Okada, Morihito
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.171
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
171
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer
    Smithers, B. Mark
    Thomson, Iain
    THORACIC SURGERY CLINICS, 2013, 23 (04) : 509 - +
  • [32] Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer
    Sugase, Takahito
    Sugimura, Keijiro
    Kanemura, Takashi
    Takeoka, Tomohira
    Yamamoto, Masaaki
    Shinno, Naoki
    Hara, Hisashi
    Omori, Takeshi
    Fujii, Yoshiaki
    Mukai, Yosuke
    Mikamori, Manabu
    Hasegawa, Shinichiro
    Haraguchi, Naotsugu
    Akita, Hirofumi
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    ONCOLOGY, 2022, : 655 - 665
  • [33] Neoadjuvant chemoradiotherapy with consecutive surgery in patients with resectable esophageal cancer.
    van de Schoot, L
    van der Sangen, M
    Creemers, GJ
    van Driel, OJR
    Rutten, HJT
    Nieuwenhuijzen, GAP
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A41 - A41
  • [34] Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal cancer
    Cheng, X.
    Chen, Y.
    Wu, X.
    Hao, D.
    Zhang, Y.
    Li, X.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Outcomes of adjuvant chemotherapy after neoadjuvant chemoradiotherapy for esophageal cancer.
    Shridhar, Ravi
    Huston, Jamie
    Meredith, Kenneth L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [36] Detection of interval metastasis after neoadjuvant chemoradiotherapy for esophageal cancer.
    Goense, L.
    Lin, S. H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S83 - S84
  • [37] Concurrent chemoradiotherapy of twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer.
    Hsu, CH
    Lin, CC
    Yeh, KH
    Chen, JC
    Ting, LL
    Lee, JM
    Lee, YC
    Ang, HPV
    Lin, JT
    Cheng, AL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 321S - 321S
  • [38] Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.
    Dane, Faysal
    Atasoy, Beste Melek
    Akgun, Zuleyha
    Yumuk, Fulden
    Cabuk, Devrim
    Teomete, Mehmet
    Basaran, Gul
    Turhal, Serdar
    Abacioglu, Ufuk
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Docetaxel, cisplatin and fluorouracil as neoadjuvant chemotherapy for esophageal cancer with prophylactic pegfilgrastim
    Maeda, Osamu
    Koike, Masahiko
    Fukaya, Masahide
    Miyata, Kazushi
    Iwata, Naoki
    Nagino, Masato
    Kodera, Yasuhiro
    Ando, Yuichi
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer
    Iwasaki, Kenichi
    Osaka, Yoshiaki
    Tachibana, Shingo
    Suda, Takeshi
    Ota, Yoshihiro
    Hoshino, Sumito
    Tsuchida, Akihiko
    ANTICANCER RESEARCH, 2016, 36 (03) : 987 - 994
12345